Drug Interaction Study of ASC42 With Atorvastatin
Condition(s):HealthyLast Updated:October 17, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):HealthyLast Updated:October 17, 2022Recruiting
Condition(s):HealthyLast Updated:July 20, 2012Completed
Condition(s):Non-segmental VitiligoLast Updated:September 23, 2020Completed
Condition(s):Alagille Syndrome; Atorvastatin; XanthomaLast Updated:August 4, 2022Recruiting
Condition(s):Atorvastatin Antihypertensive EffectLast Updated:January 10, 2023Completed
Condition(s):HealthyLast Updated:July 20, 2012Completed
Condition(s):HypercholesterolemiaLast Updated:February 21, 2021Completed
Condition(s):Recurrent Prostate Cancer; Stage I Prostate Cancer; Stage IIA Prostate Cancer; Stage IIB Prostate Cancer; Stage III Prostate Cancer; Stage IV Prostate CancerLast Updated:June 19, 2013Withdrawn
Condition(s):Acute Myocardial Infarction; Glucose Metabolism DisordersLast Updated:May 12, 2022Recruiting
Condition(s):HealthyLast Updated:December 1, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.